Stocks · News reference
Omada Health announced it will present new peer-reviewed research regarding weight loss and body composition outcomes for patients undergoing GLP-1 treatment.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Omada Health was featured in a PRISM MarketView report highlighting public companies contributing to strength, mobility, and chronic disease management during National Physical Therapy Month.
Omada Health (NASDAQ:OMDA) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered by Benzinga APIs. For